Asunaprevir
CAS No. 630420-16-5
Asunaprevir( BMS-650032 | BMS650032 | Asunaprevir )
Catalog No. M18929 CAS No. 630420-16-5
Asunaprevir is an effective hepatitis C virus (HCV) NS3 protease inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 102 | In Stock |
|
| 10MG | 170 | In Stock |
|
| 25MG | 336 | In Stock |
|
| 50MG | 512 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 500MG | 1521 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAsunaprevir
-
NoteResearch use only, not for human use.
-
Brief DescriptionAsunaprevir is an effective hepatitis C virus (HCV) NS3 protease inhibitor.
-
DescriptionAsunaprevir, also known as BMS-650032, is an inhibitor of the hepatitis C virus enzyme serine protease NS3. Asunaprevir is being tested in combination with pegylated interferon and ribavirin, as well as in interferon-free regimens with other direct-acting antiviral agents including daclatasvir.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS-650032 | BMS650032 | Asunaprevir
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorHCV NS3/4A protease
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number630420-16-5
-
Formula Weight748.29
-
Molecular FormulaC35H46ClN5O9S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 42.9 mg/mL; 57.33 mM
-
SMILESO=C([C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)N5C[C@H](Oc1ncc(OC)c2ccc(Cl)cc12)C[C@H]5C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4
-
Chemical Name1,1-dimethylethyl ((1S)-1-{((2S,4R)-4-(7-chloro-4-methoxyisoquinolin-1-yloxy)-2-({(1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl}carbamoyl) pyrrolidin-1-yl)carbonyl}-2,2-dimethylpropyl)carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pelosi LA, et al. Effect on HCV Replication by Combinations of Direct Acting Antivirals Including NS5A Inhibitor Daclatasvir. Antimicrob Agents Chemother. 2012 Jul 30.
molnova catalog
related products
-
Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
-
STAT5 inhibitor 17f
A novel potent, selective inhibitor of phosphorylation and transcriptional activity of STAT5, but not STAT3, AKT, or Erk1/2 phosphorylation.
-
Methyl L-histidinate...
Inhibition of histidine decarboxylase in Sprague-Dawley rat stomach assessed as decrease in 14CO2 production with activty value of 1.8 μM
Cart
sales@molnova.com